AAAAAA
Results:
1-18
|
Results: 18
EFFECT OF YM435, A DOPAMINE DA(1) RECEPTOR AGONIST, IN A CANINE MODELOF ISCHEMIC ACUTE-RENAL-FAILURE
Authors:
YATSU T
ARAI Y
TAKIZAWA K
KASAINAKAGAWA C
TAKANASHI M
UCHIDA W
INAGAKI O
TANAKA A
TAKENAKA T
Citation: T. Yatsu et al., EFFECT OF YM435, A DOPAMINE DA(1) RECEPTOR AGONIST, IN A CANINE MODELOF ISCHEMIC ACUTE-RENAL-FAILURE, General pharmacology, 31(5), 1998, pp. 803-807
Authors:
YATSU T
ARAI Y
SUDOH K
SHIBASAKI M
UCHIDA W
INAGAKI O
TANAKA A
TAKENAKA T
Citation: T. Yatsu et al., EFFECT OF YM435, A NOVEL DOPAMINE DA(1) RECEPTOR AGONIST, IN A CANINEMODEL OF ACUTE CONGESTIVE-HEART-FAILURE, General pharmacology, 30(5), 1998, pp. 733-737
Authors:
TAHARA A
TOMURA Y
WADA K
KUSAYAMA T
TSUKADA J
ISHII N
YATSU T
UCHIDA W
TANAKA A
Citation: A. Tahara et al., BINDING CHARACTERISTICS OF YM087, AN AVP RECEPTOR ANTAGONIST, IN RHESUS-MONKEY LIVER AND KIDNEY MEMBRANES, Peptides, 19(4), 1998, pp. 691-696
Authors:
TAHARA A
TOMURA Y
WADA K
KUSAYAMA T
TSUKADA J
ISHII N
YATSU T
UCHIDA W
TANAKA A
Citation: A. Tahara et al., CHARACTERIZATION OF VASOPRESSIN RECEPTOR IN RAT LUNG, Neuropeptides, 32(3), 1998, pp. 281-286
Authors:
TAHARA A
SAITO M
SUGIMOTO T
TOMURA Y
WADA K
KUSAYAMA T
TSUKADA J
ISHII N
YATSU T
UCHIDA W
TANAKA A
Citation: A. Tahara et al., PHARMACOLOGICAL CHARACTERIZATION OF YMO87, A POTENT, NONPEPTIDE HUMANVASOPRESSIN V-1A AND V-2 RECEPTOR ANTAGONIST, Naunyn-Schmiedeberg's archives of pharmacology, 357(1), 1998, pp. 63-69
Authors:
MATSUHISA A
KOSHIO H
SAKAMOTO K
TANIGUCHI N
YATSU T
TANAKA A
Citation: A. Matsuhisa et al., NONPEPTIDE ARGININE-VASOPRESSIN ANTAGONISTS FOR BOTH V-1A AND V-2 RECEPTORS - SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF HYDRO-1H-1,5-BENZODIAZEPINE-1-CARBONYL)BENZANILIDE DERIVATIVES, Chemical and Pharmaceutical Bulletin, 46(10), 1998, pp. 1566-1579
Authors:
TAHARA A
TOMURA Y
WADA K
KUSAYAMA T
TSUKADA J
ISHII N
YATSU T
UCHIDA W
TANAKA A
Citation: A. Tahara et al., EFFECT OF YM087, A POTENT NONPEPTIDE VASOPRESSIN ANTAGONIST, ON VASOPRESSIN-INDUCED PROTEIN-SYNTHESIS IN NEONATAL RAT CARDIOMYOCYTE, Cardiovascular Research, 38(1), 1998, pp. 198-205
Authors:
YATSU T
UCHIDA W
INAGAKI O
TANAKA A
TAKENAKA T
Citation: T. Yatsu et al., DOPAMINE DA(1) RECEPTOR AGONIST ACTIVITY OF YM435 IN THE CANINE RENALVASCULATURE, General pharmacology, 29(2), 1997, pp. 229-232
Authors:
TAHARA A
TOMURA Y
WADA K
KUSAYAMA T
TSUKADA J
ISHII N
YATSU T
UCHIDA W
TANAKA A
Citation: A. Tahara et al., EFFECT OF YM087, A POTENT NONPEPTIDE VASOPRESSIN ANTAGONIST, ON VASOPRESSIN-INDUCED HYPERPLASIA AND HYPERTROPHY OF CULTURED VASCULAR SMOOTH-MUSCLE CELLS, Journal of cardiovascular pharmacology, 30(6), 1997, pp. 759-766
HEMODYNAMIC CHARACTERIZATION OF YM435, A NOVEL DOPAMINE DA(1) RECEPTOR AGONIST, IN ANESTHETIZED DOGS
Authors:
YATSU T
TAKIZAWA K
KASAINAKAGAWA C
UCHIDA W
TANAKA A
ASANO M
HONDA K
TAKENAKA T
Citation: T. Yatsu et al., HEMODYNAMIC CHARACTERIZATION OF YM435, A NOVEL DOPAMINE DA(1) RECEPTOR AGONIST, IN ANESTHETIZED DOGS, Journal of cardiovascular pharmacology, 29(3), 1997, pp. 382-388
Authors:
YATSU T
MIYAMOTO I
KANEKOTAKANUKI F
WATANABE T
TAKENAKA T
Citation: T. Yatsu et al., PHARMACOLOGICAL AND PHARMACOKINETIC CHARACTERISTICS OF YM435, A NOVELDOPAMINE DA(1)-RECEPTOR AGONIST, IN ANESTHETIZED DOGS, Journal of Pharmacy and Pharmacology, 49(9), 1997, pp. 892-896
Authors:
TAHARA A
TOMURA Y
WADA KI
KUSAYAMA T
TSUKADA J
TAKANASHI M
YATSU T
UCHIDA W
TANAKA A
Citation: A. Tahara et al., PHARMACOLOGICAL PROFILE OF YM087, A NOVEL POTENT NONPEPTIDE VASOPRESSIN V-1A AND V-2 RECEPTOR ANTAGONIST, IN-VITRO AND IN-VIVO, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 301-308
Authors:
YATSU T
ARAI Y
TAKIZAWA K
KASAINAKAGAWA C
TAKANASHI M
UCHIDA W
INAGAKI O
TANAKA A
ASANO M
HONDA K
TAKENAKA T
Citation: T. Yatsu et al., RENAL EFFECT OF YM435, A NEW DOPAMINE D-1 RECEPTOR AGONIST, IN ANESTHETIZED DOGS, European journal of pharmacology, 322(1), 1997, pp. 45-53
Authors:
YATSU T
TOMURA Y
TAHARA A
WADA K
TSUKADA J
UCHIDA W
TANAKA A
TAKENAKA T
Citation: T. Yatsu et al., PHARMACOLOGICAL PROFILE OF YMO87, A NOVEL NONPEPTIDE DUAL VASOPRESSINV-1A AND V-2 RECEPTOR ANTAGONIST, IN DOGS, European journal of pharmacology, 321(2), 1997, pp. 225-230
Authors:
MATSUHISA A
TANAKA A
KIKUCHI K
SHIMADA Y
YATSU T
YANAGISAWA I
Citation: A. Matsuhisa et al., NONPEPTIDE ARGININE-VASOPRESSIN ANTAGONISTS FOR BOTH V-1A AND V-2 RECEPTORS - SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF TRAHYDRO-1H-1-BENZAZEPIN-1-YL)CARBONYL]BENZANILIDE DERIVATIVES, Chemical and Pharmaceutical Bulletin, 45(11), 1997, pp. 1870-1874
Authors:
TOMURA Y
YATSU T
UCHIDA W
INAGAKI O
TANAKA A
TOMIOKA K
YANAGISAWA I
TOICHI T
Citation: Y. Tomura et al., ACUTE AND CHRONIC ADMINISTRATION OF YM087, A NONPEPTIDE VASOPRESSIN ANTAGONIST, IN RATS WITH HIGH-OUTPUT HEART-FAILURE, Circulation, 94(8), 1996, pp. 1544-1544
Authors:
ANAN H
TANAKA A
TSUZUKI R
YOKOTA M
YATSU T
FUJIKURA T
Citation: H. Anan et al., ,4-DIHYDROXYPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES .2. THEIR RENAL VASODILATION ACTIVITY AND STRUCTURE-ACTIVITY RELATIONSHIP, Chemical and Pharmaceutical Bulletin, 44(10), 1996, pp. 1865-1870
Authors:
FUKUSHIMA O
ARAKAWA H
KITADA M
MIYAMURA M
YATSU T
KISHIMOTO K
YAMASHITA H
Citation: O. Fukushima et al., DISPLACEMENT OF ACID-PHOSPHATASE AND ALKALINE-PHOSPHATASE PROTEINS INTHE RAT-KIDNEY DURING A DEHYDRATION PROCEDURE - AN ADVANTAGE OF ULTRATHIN FROZEN-SECTIONS FOR DETECTING PRECISE LOCALIZATION OF AN ENZYME-ACTIVITY, Acta histochemica et cytochemica, 28(2), 1995, pp. 143-148
Risultati:
1-18
|